Device maker TriVascular Technologies plans an IPO in hopes of raising as much as $100 million to repay Boston Scientific, build up sales & marketing and fund additional R&D.
California medical device maker TriVascular Technologies is looking to raise as much as $100 million through its initial public offering, the details of which have yet to be finalized.
New York's AngioDynamics wins updated labeling from FDA regulators, indicating its AngioVac venous drainage system for up to 6 hours at a time.
AngioDynamics (NSDQ:ANGO) tallied a new win for its AngioVac drainage system, with new FDA clearance to market the device for extended use.
OrbusNeich says it began enrolling patients in the Harmonee clinical trial of its Combo dual-therapy coronary stent, ahead of a planned bid for Japanese Shonin approval.
OrbusNeich Medical said it launched a clinical trial in the U.S. and Japan for its Combo dual-therapy coronary stent as it gears up to apply for Shonin approval in Japan.
Medical lasers maker Biolase is still examining "strategic alternatives" for the company as its slashes about $1.3 million from its payroll and posts continued quarterly losses.
California medtech company Biolase (NSDQ:BIOL) is looking to slim down ahead of a potential acquisition as the company examines its "strategic alternatives."
Wright Medical says it struck a deal with the FDA to submit more data on its Augment bone graft, previously deemed unapprovable by the watchdog agency.
Wright Medical (NSDQ:WMGI) said the FDA agreed to let it submit additional data for its pre-market approval application for the Augment bone graft it bought along with BioMimetic Therapeutics in 2012.
British medical device maker Lombard Medical says it could raise as much as $80 million in its U.S. initial public offering.
Lombard Medical Technologies (LON:LMT) said yesterday that it could raise up to $80 million in its debut on the U.S. stock market.
FDA regulators put their highest-risk label on a recall of Philips Respironics' Trilogy ventilators, pulled over concerns that a faulty component may endanger mechanical breathing support.
MASSDEVICE ON CALL — Philips Healthcare (NYSE:PHG) subsidiary Respironics got the FDA's highest-level warning over a recall of certain Trilogy ventilators.
Need Medtech news in a minute? We Deliver!
MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.
News and information for the medical device industry and the companies that drive it. Learn the latest about sales, jobs, legislation and other areas of the medtech industry.